Paradoxical synergistic effects of tumour necrosis factor and interleukin 1 in murine gut-derived sepsis with Pseudomonas aeruginosa

Cytokine

Volumn 11, Issue 5, 1999, Pages 366-372

  Matsumoto, Tetsuya ^a   Tateda, Kazuhiro ^a   Miyazaki, Shuichi ^a   Furuya, Nobuhiko ^a   Ohno, Akira ^a   Ishii, Yoshikazu ^a   Hirakata, Yoichi ^b   Yamaguchi, Keizo ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bacterial translocation; IL 1; Pseudomonas aeruginosal sepsis; TNF

Indexed keywords

CYCLOPHOSPHAMIDE; RECOMBINANT INTERLEUKIN 1ALPHA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; DRUG POTENTIATION; GASTROINTESTINAL INFECTION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0032904577     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0434     Document Type: Article

References (39)

1. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 229:1985;869-871.
2. Remick DG, Strieter RM, Lynch JD, Nguyen D, Eskandari M, Kunkel SL. In vivo dynamics of murine tumor necrosis factor-alpha gene expression. Kinetics of dexamethasone-induced suppression. Lab Invest. 60:1989;766-771.
3. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 330:1987;662-664.
4. Alexander HR, Doherty GM, Fraker DL, Block MI, Swedenborg JE, Norton JA. Human recombinant interleukin-1 alpha protection against the lethality of endotoxin and experimental sepsis in mice. J Surg Res. 50:1991;421-424.
5. Alexander HR, Doherty GM, Venzon DJ, Merino MJ, Fraker DL, Norton JA. Recombinant interleukin-1 receptor antagonist (IL-1ra): effective therapy against gram-negative sepsis in rats. Surgery. 112:1992;188-193.
6. Stone R. Search for sepsis drugs goes on despite past failures. Science. 264:1994;365-367.
7. Bryan CS, Reynolds KL, Brenner ER. Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev Infect Dis. 5:1983;629-638.
8. Dick JD, Shull V, Karp JE, Valentine J. Bacterial and host factors affecting Pseudomonas aeruginosa colonization versus bacteremia in granulocytopenic patients. Eur J Cancer Clin Oncol. 25:1988;S47-54.
9. Young LS, Stevens P, Kaijser B. Gram-negative pathogens in septicemic infections. Scand J Infect Dis. 31:1982;78-94.
10. Hirakata Y, Kaku M, Tomono K, Tateda K, Furuya N, Matsumoto T, Araki R, Yamaguchi K. Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice. Antimicrob Agents Chemother. 36:1992;1198-1203.
11. Matsumoto T, Tateda K, Miyazaki S, Furuya N, Ohno A, Ishii Y, Hirakata Y, Yamaguchi K. Adverse effects of tumor necrosis factor in cyclophosphamide-treated mice subjected to gut-derived Pseudomonas aeruginosa sepsis. Cytokine. 9:1997;763-769.
12. Matsumoto T, Tateda K, Miyazaki S, Furuya N, Ohno A, Ishii Y, Hirakata Y, Yamaguchi K. Immunomodulating effect of fosfomycin on gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob Agents Chemother. 41:1997;308-313.
13. Waage A, Espevik T. Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice. J Exp Med. 167:1988;1987-1992.
14. Brouckaert PG, Everaerdt B, Libert C, Takahashi N, Fiers W. Species specificity and involvement of other cytokines in endotoxic shock action of recombinant tumour necrosis factor in mice. Agents Actions. 26:1989;196-198.
15. Cohen-Kaminsky S, Delattre RM, Devergne O, Rouet P, Gimond D, Berrih-Aknin S, Galanaud P. Synergistic induction of interleukin-6 production and gene expression in human thymic epithelial cells by LPS and cytokines. Cell Immunol. 138:1991;79-93.
16. Cross AS, Sadoff JC, Kelly N, Bernton E, Gemski P. Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection. J Exp Med. 169:1989;2021-2027.
17. Amura CR, Fontan PA, Sanjuan N, Sordelli DO. The effect of treatment with interleukin-1 and tumor necrosis factor on Pseudomonas aeruginosa lung infection in a granulocytopenic mouse model. Clin Immunol Immunopath. 73:1994;261-266.
18. Dinarello CA. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis. 163:1991;1177-1184.
19. Dinarello CA. The biology of interleukin 1 and comparison to tumor necrosis factor. Immunol Letters. 16:1987;227-231.
20. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest. 81:1988;1162-1172.
21. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, Figari IS, Palladino MA Jr., O'Connor JV. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med. 163:1986;1433-1450.
22. Caldwell J, Emerson SG. Interleukin-1 alpha upregulates tumor necrosis factor receptors expressed by a human bone marrow stromal cell strain: implications for cytokine redundancy and synergy. Blood. 86:1995;3364-3372.
23. Beasley D, Eldridge M. Interleukin-1 beta and tumor necrosis factor-alpha synergistically induce NO synthase in rat vascular smooth muscle cells. Am J Physiol. 266:1994;R1197-1203.
24. Pastor C, Teisseire B, Vicaut E, Payen D. Effects of L-arginine and L-nitro-arginine treatment on blood pressure and cardiac output in a rabbit endotoxin shock model. Crit Care Med. 22:1994;465-469.
25. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res. 28:1994;34-39.
26. Tsuneyoshi I, Kanmura Y, Yoshimura N. Nitric oxide as a mediator of reduced arterial responsiveness in septic patients. Crit Care Med. 24:1996;1083-1086.
27. Alexander HR, Sheppard BC, Jensen JC, Langstein HN, Buresh CM, Venzon D, Walker EC, Fraker DL, Stovroff MC, Norton JA. Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis. J Clin Invest. 88:1991;34-39.
28. Morikage T, Mizushima Y, Yano S. Prevention of bacterial infection and LPS-induced lethality by interleukin-1 alpha in mice. Tohoku J Exp Med. 163:1991;47-57.
29. Wells CL, Podzorski RP, Peterson PK, Ramsay NK, Simmons RL, Rhame FS. Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients. J Infect Dis. 150:1984;699-706.
30. Tancrede CH, Andremont AO. Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies. J Infect Dis. 152:1985;99-103.
31. Berg RD, Garlington AW. Translocation of Escherichia coli from the gastrointestinal tract to the mesenteric lymph nodes in gnotobiotic mice receiving Escherichia coli vaccines before colonization. Infect Immun. 30:1980;894-898.
32. Deitch EA, Winterton J, Berg R. Thermal injury promotes bacterial translocation from the gastrointestinal tract in mice with impaired T-cell-mediated immunity. Arch Surg. 121:1986;97-101.
33. Maejima K, Deitch E, Berg R. Promotion by burn stress of the translocation of bacteria from the gastrointestinal tracts of mice. Arch Surg. 119:1984;166-172.
34. Maejima K, Deitch EA, Berg RD. Bacterial translocation from the gastrointestinal tracts of rats receiving thermal injury. Infect Immun. 43:1984;6-10.
35. Mainous MR, Ertel W, Chaudry IH, Deitch EA. The gut: a cytokine-generating organ in systemic inflammation? Shock. 4:1995;193-199.
36. Fukumura D, Miura S, Kurose I, Higuchi H, Suzuki H, Ebinuma H, Han JY, Watanabe N, Wakabayashi G, Kitajima M, Ishii H. IL-1 is an important mediator for microcirculatory changes in endotoxin-induced intestinal mucosal damage. Digest Dis Sciences. 41:1996;2482-2492.
37. Hirakata Y, Tomono K, Tateda K, Matsumoto T, Furuya N, Shimoguchi K, Kaku M, Yamaguchi K. Role of bacterial association with Kupffer cells in occurrence of endogenous systemic bacteremia. Infect Immun. 59:1991;289-294.
38. Matsumoto T, Tateda K, Miyazaki S, Furuya N, Ohno A, Ishii Y, Hirakata Y, Yamaguchi K. Effect of immunisation with Pseudomonas aeruginosa on gut-derived sepsis in mice. J Med Microbiol. 47:1998;295-301.
39. Matsumoto T, Tateda K, Furuya N, Miyazaki S, Ohno A, Ishii Y, Hirakata Y, Yamaguchi K. Efficacies of alkaline protease, elastase, and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice. J Med Microbiol. 47:1998;303-308.